469 related articles for article (PubMed ID: 28604802)
21. Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan.
Kawai K; Kawai A
Intern Med; 1992 Mar; 31(3):313-8. PubMed ID: 1319246
[TBL] [Abstract][Full Text] [Related]
22. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis.
Wagner HJ; Hennig H; Jabs WJ; Siekhaus A; Wessel K; Wandinger KP
Viral Immunol; 2000; 13(4):497-502. PubMed ID: 11192296
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.
Ruiz-Pablos M; Paiva B; Montero-Mateo R; Garcia N; Zabaleta A
Front Immunol; 2021; 12():656797. PubMed ID: 34867935
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
26. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.
Falk K; Linde A; Johnson D; Lennette E; Ernberg I; Lundkvist A
J Med Virol; 1995 Aug; 46(4):349-57. PubMed ID: 7595412
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus nuclear antigen-2 detection and typing in immunocompromised children correlated with lymphoproliferative disorder biopsy findings.
Mendes TM; Oliveira LC; Yamamoto L; Del Negro GM; Okay TS
Braz J Infect Dis; 2008 Jun; 12(3):186-91. PubMed ID: 18833401
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
29. Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.
Fogg MH; Wirth LJ; Posner M; Wang F
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3318-23. PubMed ID: 19211798
[TBL] [Abstract][Full Text] [Related]
30. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
[TBL] [Abstract][Full Text] [Related]
31. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
Harada S; Kamata Y; Ishii Y; Eda H; Kitamura R; Obayashi M; Ito S; Ban F; Kuranari J; Nakajima H; Kuze T; Hayashi M; Okabe N; Senpuku H; Miyasaka N; Nakamura Y; Kanegane H; Yanagi K
Clin Diagn Lab Immunol; 2004 Jan; 11(1):123-30. PubMed ID: 14715558
[TBL] [Abstract][Full Text] [Related]
32. The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes.
Tedeschi R; Foong YT; Cheng HM; dePaoli P; Lehtinen T; Elfborg T; Dillner J
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1393-400. PubMed ID: 7540196
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
Castellazzi M; Delbue S; Elia F; Gastaldi M; Franciotta D; Rizzo R; Bellini T; Bergamaschi R; Granieri E; Fainardi E
Dis Markers; 2015; 2015():901312. PubMed ID: 26101453
[TBL] [Abstract][Full Text] [Related]
34. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
[TBL] [Abstract][Full Text] [Related]
35. Molecular diversity of IgG responses to Epstein-Barr virus proteins in asymptomatic Epstein-Barr virus carriers.
Goswami R; Shair KHY; Gershburg E
J Gen Virol; 2017 Sep; 98(9):2343-2350. PubMed ID: 28795661
[TBL] [Abstract][Full Text] [Related]
36. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.
Jog NR; McClain MT; Heinlen LD; Gross T; Towner R; Guthridge JM; Axtell RC; Pardo G; Harley JB; James JA
J Autoimmun; 2020 Jan; 106():102332. PubMed ID: 31515129
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins.
Mechelli R; Anderson J; Vittori D; Coarelli G; Annibali V; Cannoni S; Aloisi F; Salvetti M; James JA; Ristori G
Mult Scler; 2011 Nov; 17(11):1290-4. PubMed ID: 21757535
[TBL] [Abstract][Full Text] [Related]
39. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
[TBL] [Abstract][Full Text] [Related]
40. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein.
Bray PF; Luka J; Bray PF; Culp KW; Schlight JP
Neurology; 1992 Sep; 42(9):1798-804. PubMed ID: 1381067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]